Eli Lilly and Company (LLY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-1992 | 09-1992 | 06-1992 | 03-1992 | 12-1991 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 708,700 | N/A | N/A | N/A | 1,314,700 |
| Depreciation Amortization | 368,100 | N/A | N/A | N/A | 299,500 |
| Other Working Capital | -77,400 | N/A | N/A | N/A | -337,200 |
| Other Operating Activity | 484,100 | 0 | 0 | 0 | -22,400 |
| Operating Cash Flow | $1,483,500 | $N/A | $N/A | $N/A | $1,254,600 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -803,400 | N/A | N/A | N/A | -1,113,900 |
| Net Acquisitions | -89,200 | N/A | N/A | N/A | N/A |
| Other Investing Activity | -35,600 | 0 | 0 | 0 | 258,200 |
| Investing Cash Flow | $-928,200 | $N/A | $N/A | $N/A | $-855,700 |
| Cash Flows From Financing Activities | |||||
| Dividend Paid | -643,700 | N/A | N/A | N/A | -582,700 |
| Other Financing Activity | 55,100 | 0 | 0 | 0 | 304,500 |
| Financing Cash Flow | $-588,600 | $N/A | $N/A | $N/A | $-278,200 |
| Exchange Rate Effect | -13,500 | N/A | N/A | N/A | 8,300 |
| Beginning Cash Position | 479,200 | N/A | N/A | N/A | 350,200 |
| End Cash Position | 432,400 | N/A | N/A | N/A | 479,200 |
| Net Cash Flow | $-46,800 | $N/A | $N/A | $N/A | $129,000 |
| Free Cash Flow | |||||
| Operating Cash Flow | 1,483,500 | N/A | N/A | N/A | 1,254,600 |
| Free Cash Flow | 1,483,500 | 0 | 0 | 0 | 1,254,600 |